Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.2 - $0.5 $14,031 - $35,079
-70,158 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.41 - $0.63 $7,272 - $11,174
-17,738 Reduced 20.18%
70,158 $39,000
Q3 2021

Nov 15, 2021

SELL
$1.11 - $1.7 $153,275 - $234,746
-138,086 Reduced 61.1%
87,896 $108,000
Q2 2021

Aug 16, 2021

BUY
$1.46 - $2.25 $329,933 - $508,459
225,982 New
225,982 $382,000
Q2 2018

Aug 14, 2018

SELL
$1.44 - $2.24 $128,391 - $199,720
-89,161 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$1.51 - $2.06 $1,428 - $1,948
-946 Reduced 1.05%
89,161 $146,000
Q3 2017

Nov 13, 2017

BUY
$2.22 - $2.79 $200,037 - $251,398
90,107
90,107 $230,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.